ArticleMolecules (Basel, Switzerland)2022

From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease.

Matthias Göhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.